Companies
Adverum Biotechnologies (ADVM) Shares Surge Following Positive Clinical Trial Data
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) stock is in a bull market following the announcement of positive clinical trial findings. After rising 7.97% the previous day
